Leukotriene B4
- Generic Name
- Leukotriene B4
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H32O4
- CAS Number
- 71160-24-2
- Unique Ingredient Identifier
- 1HGW4DR56D
- Background
Leukotriene B4 has been used in trials studying the treatment of HIV Infections.
- Associated Conditions
- -
- Associated Therapies
- -
Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-06-20
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 12
- Registration Number
- NCT03192280
- Locations
- 🇦🇺
Investigational Site, Herston, Australia
A Pilot Study of LTB4 in HIV-1 Infected Adults
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-11-10
- Last Posted Date
- 2006-07-10
- Lead Sponsor
- LTB4 Sweden AB
- Target Recruit Count
- 40
- Registration Number
- NCT00251537
- Locations
- 🇨🇦
Centre Hospitalier Universitaire de Quebec, Ste-Foy, Quebec, Canada
🇨🇦Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada
🇨🇦Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath